Stock Events

Stock Events

Kaken Pharmaceutical (4521.TSE) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-139

24

188

351

Details

Expected EPS

N/A

Actual EPS

-139

Surprise EPS

-139

Surprise Percent

+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of -139 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.